Danaher shares jump 7% as the turnaround in biotech spending finally arrives

Earnings

In this photo illustration, a Danaher Corporation logo seen displayed on a tablet. 
Igor Golovnov | SOPA Images | Lightrocket | Getty Images

Shares of Danaher popped more than 7% on Tuesday after the life sciences company delivered beats across its three main businesses — a sign the long-awaited turnaround in the biotech industry is finally here.

Articles You May Like

Pandemic Stock Winners Shopify, Peloton and Zoom: Buying Opportunities in 2025?
Zacks Strategist Shaun Pruitt Discusses The Real Trump Trade
Astera Labs (ALAB) and Cracker Barrel Old Country Store (CBRL): 10/6/25 Bull & Bear
3 Top Stocks That Aren’t the Mag 7